Anthracycline Dose Intensification in Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Fernandez, Hugo F. [1 ]
Rowe, Jacob M. [2 ]
Tallman, Martin S. [3 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Rambam Med Ctr, Haifa, Israel
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 26期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2578 / 2578
页数：1
相关论文
共 50 条
  • [21] Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax
    Hara, Ryujiro
    Machida, Shinichiro
    Hashimoto, Norisato
    Ogiya, Daisuke
    Kawai, Hidetsugu
    Kawakami, Shohei
    Shiraiwa, Sawako
    Onizuka, Makoto
    Ogawa, Yoshiaki
    Kawada, Hiroshi
    Ando, Kiyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (06) : 711 - 717
  • [22] Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax
    Ryujiro Hara
    Shinichiro Machida
    Norisato Hashimoto
    Daisuke Ogiya
    Hidetsugu Kawai
    Shohei Kawakami
    Sawako Shiraiwa
    Makoto Onizuka
    Yoshiaki Ogawa
    Hiroshi Kawada
    Kiyoshi Ando
    International Journal of Hematology, 2023, 118 : 711 - 717
  • [23] Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia
    Mort, Joseph F.
    Brighton, David
    Dibenedetto, Samantha
    Wells, Leah
    Clark, Stephen M.
    Reid, Justin
    Patel, Imari
    Jackson, Clayton
    Yelvington, Bradley
    Miller, Ryan
    Perciavalle, Matthew
    Walsh, Katherine
    Wolfe, Heather
    Locke, Susan C.
    Zeidner, Joshua F.
    Duong, Vu H.
    Reed, Daniel R.
    Dholaria, Bhagirathbhai
    Leblanc, Thomas W.
    Keng, Michael
    Horton, Bethany
    El Chaer, Firas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (03) : 481 - 494
  • [24] Clofarabine plus anthracycline combinations in acute myeloid leukemia (AML) salvage.
    Faderl, Stefan
    Ferrajoli, Alessandra
    Ravandi-Kashani, Farhad
    Verstovsek, Srdan
    Wierda, William G.
    Borthakur, Gautam
    Thomas, Deborah
    Cortes, Jorge
    Komblau, Steven M.
    Estrov, Zeev
    Andreeff, Michael
    Beran, Miloslav
    Giles, Francis
    Huang, Xuelin
    Kwari, Monica
    Kantarjian, Hagop M.
    BLOOD, 2006, 108 (11) : 51A - 51A
  • [25] Correlation between mon phenotype and anthracycline drugs in acute myeloid leukemia (AML)
    Belotti, D
    Pogliani, EM
    Piazza, M
    Corneo, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1317 - 1317
  • [26] High-dose anthracycline induction in adult acute lymphocytic leukemia
    Todeschini, G
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (01) : 9 - +
  • [27] Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
    von Korn P.
    Vogt M.
    Oberhoffer R.
    Ewert P.
    Müller J.
    Cardio-Oncology, 2 (1)
  • [28] Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia
    Mouchel, Pierre-Luc
    Serhan, Nizar
    Betous, Remy
    Farge, Thomas
    Saland, Estelle
    De Medina, Philippe
    Hoffmann, Jean-Sebastien
    Sarry, Jean-Emmanuel
    Poirot, Marc
    Silvente-Poirot, Sandrine
    Recher, Christian
    CANCERS, 2020, 12 (10) : 1 - 14
  • [29] Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants
    Choi, Eun-Ji
    Lee, Je-Hwan
    Lee, Jung-Hee
    Park, Han-Seung
    Ko, Sun-Hye
    Seol, Miee
    Woo, Ji Min
    Lee, Kyoo-Hyung
    BLOOD, 2016, 128 (22)
  • [30] Prediction of Early Death in Acute Myeloid Leukemia Reply
    Walter, Roland B.
    Othus, Megan
    Estey, Elihu H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04) : 463 - 464
12345